DIGNITANA FUELS GROWTH WITH NINE NEW INSTALLATIONS IN U.S. FOR DigniCap® SCALP COOLING MEDICAL DEVICE
Lund, Sweden – February 22, 2017—Dignitana, a global leader in medical scalp-cooling technology, announced today that the DigniCap® scalp cooling system, which was cleared in December 2015 by the FDA to effectively reduce the likelihood of chemotherapy-induced hair loss in women with breast cancer, will soon be available in nine additional medical centers across the United States including the four locations of University of Miami Health System that were contracted in November 2016. The DigniCap® system is the first scalp cooling device to complete rigorous FDA clinical trials in America,